A_DT
p56lck-independent_JJ
pathway_NN
of_IN
CD2_NN
signaling_NN
involves_VBZ
Jun_NN
kinase_NN
._.

The_DT
p56_NN
Src_NN
family_NN
non-receptor_JJ
tyrosine_NN
kinase_NN
has_VBZ
been_VBN
shown_VBN
to_TO
be_VB
critical_JJ
for_IN
T_NN
lymphocyte_NN
differentiation_NN
and_CC
activation_NN
._.

Hence_RB
in_IN
the_DT
absence_NN
of_IN
p56_NN
,_,
T_NN
cell_NN
receptor_NN
triggered_VBD
activation_NN
does_VBZ
not_RB
occur_VB
._.

We_PRP
now_RB
provide_VBP
evidence_NN
for_IN
a_DT
CD2-based_JJ
signaling_NN
pathway_NN
which_WDT
,_,
in_IN
contrast_NN
to_TO
that_DT
of_IN
the_DT
T_NN
cell_NN
receptor_NN
,_,
is_VBZ
independent_JJ
of_IN
p56_NN
._.

CD2-mediated_JJ
interleukin-2_NN
production_NN
occurs_VBZ
via_IN
activation_NN
of_IN
Jun_NN
kinase_NN
in_IN
cell_NN
lines_NNS
lacking_VBG
p56_NN
._.

Jun_NN
kinase_NN
then_RB
facilitates_VBZ
the_DT
binding_NN
of_IN
c-Jun\/c-Fos_NN
heterodimers_NNS
to_TO
the_DT
AP-1_NN
consensus_NN
site_NN
and_CC
the_DT
subsequent_JJ
transcriptional_JJ
activity_NN
of_IN
the_DT
interleukin-2_NN
promoter_NN
._.

These_DT
data_NNS
elucidate_VBP
differences_NNS
between_IN
TCR_NN
and_CC
CD2_NN
signaling_NN
pathways_NNS
in_IN
the_DT
same_JJ
T_NN
cells_NNS
._.

